193 related articles for article (PubMed ID: 22387673)
21. Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries.
Hemminki K; Bevier M; Sundquist J; Hemminki A
Int J Cancer; 2013 Feb; 132(4):944-50. PubMed ID: 22730111
[TBL] [Abstract][Full Text] [Related]
22. An audit of cancer of unknown primary notifications: A cautionary tale for population health research using cancer registry data.
Vajdic CM; Er CC; Schaffer A; Dobbins T; Wyld L; Meagher NS; Barrett J; Ward RL; Pearson SA
Cancer Epidemiol; 2014 Aug; 38(4):460-4. PubMed ID: 24929356
[TBL] [Abstract][Full Text] [Related]
23. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study.
Seve P; Sawyer M; Hanson J; Broussolle C; Dumontet C; Mackey JR
Cancer; 2006 May; 106(9):2058-66. PubMed ID: 16583433
[TBL] [Abstract][Full Text] [Related]
24. Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of Sweden.
Bratt O; Berglund A; Adolfsson J; Johansson JE; Törnblom M; Stattin P;
Scand J Urol Nephrol; 2010 Dec; 44(6):384-90. PubMed ID: 20624113
[TBL] [Abstract][Full Text] [Related]
25. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
[TBL] [Abstract][Full Text] [Related]
26. Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries.
Hakulinen T; Andersen A; Malker B; Pukkala E; Schou G; Tulinius H
Acta Pathol Microbiol Immunol Scand Suppl; 1986; 288():1-151. PubMed ID: 3465196
[TBL] [Abstract][Full Text] [Related]
27. Skin disease and malignancy. An epidemiological study.
Sigurgeirsson B
Acta Derm Venereol Suppl (Stockh); 1992; 178():1-110. PubMed ID: 1288038
[TBL] [Abstract][Full Text] [Related]
28. The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival.
Varenhorst E; Garmo H; Holmberg L; Adolfsson J; Damber JE; Hellström M; Hugosson J; Lundgren R; Stattin P; Törnblom M; Johansson JE
Scand J Urol Nephrol; 2005; 39(2):117-23. PubMed ID: 16019764
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of cancer of unknown primary, today and future].
Shibata H
Gan To Kagaku Ryoho; 2009 Jun; 36(6):918-22. PubMed ID: 19542712
[TBL] [Abstract][Full Text] [Related]
30. Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis.
Hemminki K; Lenner P; Sundquist J; Bermejo JL
J Clin Oncol; 2008 Apr; 26(11):1850-7. PubMed ID: 18347006
[TBL] [Abstract][Full Text] [Related]
31. Proportion and characteristics of men with unknown risk category in the National Prostate Cancer Register of Sweden.
Tomic K; Westerberg M; Robinson D; Garmo H; Stattin P
Acta Oncol; 2016 Dec; 55(12):1461-1466. PubMed ID: 27749139
[TBL] [Abstract][Full Text] [Related]
32. Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency.
Bensing S; Brandt L; Tabaroj F; Sjöberg O; Nilsson B; Ekbom A; Blomqvist P; Kämpe O
Clin Endocrinol (Oxf); 2008 Nov; 69(5):697-704. PubMed ID: 18727712
[TBL] [Abstract][Full Text] [Related]
33. Cancer trends in Sweden until 2010.
Acta Oncol; 1996; 35 Suppl 6():37-45. PubMed ID: 9154084
[TBL] [Abstract][Full Text] [Related]
34. Cancer incidence in southern Iran, 1998-2002: results of population-based cancer registry.
Masoompour SM; Yarmohammadi H; Rezaianzadeh A; Lankarani KB
Cancer Epidemiol; 2011 Oct; 35(5):e42-7. PubMed ID: 21840285
[TBL] [Abstract][Full Text] [Related]
35. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
[TBL] [Abstract][Full Text] [Related]
36. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
37. Switching benchmarks in cancer of unknown primary: from autopsy to microarray.
Pentheroudakis G; Golfinopoulos V; Pavlidis N
Eur J Cancer; 2007 Sep; 43(14):2026-36. PubMed ID: 17698346
[TBL] [Abstract][Full Text] [Related]
38. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.
Riihimäki M; Thomsen H; Hemminki A; Sundquist K; Hemminki K
BMC Cancer; 2013 Jan; 13():36. PubMed ID: 23356713
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of prognostic factors in 68 patients with cancer of unknown primary site].
Kou XG; Liang DL; Zhang QQ; Li XR; Zhao YZ; Gu JF; Lu P
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):783-6. PubMed ID: 22335913
[TBL] [Abstract][Full Text] [Related]
40. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006.
Bray F; Klint A; Gislum M; Hakulinen T; Engholm G; Tryggvadóttir L; Storm HH
Acta Oncol; 2010 Jun; 49(5):644-54. PubMed ID: 20151937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]